Literature DB >> 25056191

Tissue transglutaminase on trophoblast cells as a possible target of autoantibodies contributing to pregnancy complications in celiac patients.

Cecilia Sóñora1, Guillermina Calo, Laura Fraccaroli, Claudia Pérez-Leirós, Ana Hernández, Rosanna Ramhorst.   

Abstract

PROBLEM: Women with celiac disease (CD) are often affected by atypical presentations of the disease associated with reproductive disorders as a main extra-digestive complaint. Here, we analyzed if autoantibodies against tissue transglutaminase (tTG) in sera from CD patients with reproductive disorders could display direct effects through their interaction with tTG expressed on trophoblast cells and phagocytes inducing tissue damage and interfering in the clearance of trophoblast apoptotic bodies. METHOD OF STUDY: Sera from CD women with reproductive disorders were obtained, and their ability to induce apoptosis of Swan-71 (cytotrophoblast cell line) and to modulate the wound-healing and phagocytes process was tested.
RESULTS: Swan-71 cells expressed tTG and CD sera displayed a significant decrease in trophoblast cell migration and a delay in injury healing on trophoblast cells, compared with those observed with control sera. Moreover, CD sera significantly reduced trophoblast cell proliferation and increased apoptosis levels in comparison with those observed in the control sera. Finally, autoantibodies against tTG interfere in the clearance of trophoblast apoptotic bodies through a mechanism involving MFG-E8 (milk fat globulin-EGF factor 8)-tTG binding.
CONCLUSION: The anti-tTG antibodies might contribute to trophoblast damage and disrupt the phagocytosis process of apoptotic bodies that could promote a pro-inflammatory microenvironment.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Celiac patients; pregnancy complications; tissue transglutaminase

Mesh:

Substances:

Year:  2014        PMID: 25056191     DOI: 10.1111/aji.12290

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  5 in total

Review 1.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

2.  Pregnancy and coeliac disease.

Authors:  Kim Boers; Tom Vlasveld; Roxy van der Waart
Journal:  BMJ Case Rep       Date:  2019-12-29

3.  Unrecognised coeliac disease among men and women undergoing fertility treatment: A screening study.

Authors:  Louise B Grode; Inge E Agerholm; Peter Humaidan; Tina Parkner; Bodil H Bech; Cecilia H Ramlau-Hansen; Thomas M Jensen
Journal:  United European Gastroenterol J       Date:  2018-08-24       Impact factor: 4.623

Review 4.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

Review 5.  Tools Used to Measure the Physical State of Women with Celiac Disease: A Review with a Systematic Approach.

Authors:  Alejandro Martínez-Rodríguez; Daniela Alejandra Loaiza-Martínez; Javier Sánchez-Sánchez; Pablo J Marcos-Pardo; Soledad Prats; Fernando Alacid; Jacobo A Rubio-Arias
Journal:  Int J Environ Res Public Health       Date:  2020-01-15       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.